Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin
By P. Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-rui Si, Yan Zhu, Bei Li, Chao Huang and 18 more. bioRxiv, 2020
860 citations recorded by the source corpus.
Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome related coronaviruses (SARSr-CoV) have been discovered in their natural reservoir host, bats1-4. Previous studies indicated that some of those bat SARSr-CoVs have the potential to infect humans5-7. Here we report the identification and characterization of a novel coronavirus (nCoV-2019) which caused an epidemic of acute respiratory syndrome in humans, in Wuhan, China. The epidemic, started from December 12th, 2019, has caused 198 laboratory confirmed infections with three fatal cases by January 20th, 2020. Full-length genome sequences were obtained from five patients at the early stage of the outbreak. They are almost identical to each other and share 79.5% sequence identify to SARS-CoV. Furthermore, it was found that nCoV-2019 is 96% identical at the whole genome level to a bat coronavirus. The pairwise protein sequence analysis of seven conserved non-structural proteins show that this virus belongs to the species of SARSr-CoV. The nCoV-2019 virus was then isolated from the bronchoalveolar lavage fluid of a critically ill patient, which can be neutralized by sera from several patients. Importantly, we have confirmed that this novel CoV uses the same cell entry receptor, ACE2, as SARS-CoV.
Subfields: Animal Science and Zoology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/2ad0423e846f5039e86657298e6098214f40eee0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Animal Science and Zoology
In Infectious Diseases
Citations in the corpus
- COVID-19: what has been learned and to be learned about the novel coronavirus disease (2020, methodology): “Human ACE2 was found to be a receptor for SARSCoV-2 as well as SARS-CoV [16,18,19].”
- Seasonality of Respiratory Viral Infections. (2020, background): “Furthermore, emerging virus epidemics, such as the 2002–2003 severe acute respiratory syndrome coronavirus (SARS-CoV) and the recently emerged SARS-CoV-2, occur during the winter months (4–7), indicating that the winter environment promotes the spread of a variety of respiratory virus infections.”
- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV (2020, background): “The 2019 novel coronavirus (2019-nCoV) is a newly emerged human-infectious coronavirus (CoV) that originated in a Wuhan seafood market but has quickly spread in and beyond China.”
- Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses (2020, neutral): “It has been reported that 2019-nCoV uses the same cell entry receptor, ACE2, to infect humans, as SARS-CoV [8], so clinical similarity between the two viruses could be expected,”
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody (2020, background): “These results indicate that ACE2 could be the potential 109 receptor for the new coronavirus, and that the expressed 2019-nCoV RBD protein is 110 functional [2].”
- Pattern of early human-to-human transmission of Wuhan 2019-nCoV (2020, methodology): “The increasing research activity on 2019-nCoV has led to estimates of animal-tohuman transmission [12], estimates of epidemic size using air travel data [8, 13], and a better characterisation of the epidemiological and virological characteristics of the virus [14, 2].”
- Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study (2020, background): “Still, the early 2019-nCoV genomes that have been sequenced and uploaded are over 99% similar, suggesting these infections result from a recent cross-species event [12,31,41].”
- COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses (2020, neutral): “Bat CoV RaTG13 Showed high sequence identity to SARS-CoV-2 [42].”
- Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants (2020, neutral): “10% nucleotide similarity with SARS-CoV genes [6, 7].”
- Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 (2020, background): “Only a few days later, Chinese authorities identified and characterised a novel coronavirus (2019-nCoV) as the causative agent of the outbreak [3].”
- Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review (2020, background): “And the current reference name for the virus is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).”
- Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag (2020, background): “Another group from China had documented three insertions comparing fewer spike glycoprotein sequences of coronaviruses (Zhou et al., 2020). value.”